Jane Cheriè Yaciuk
 
Education
o    Diploma, Oklahoma School of Science and Mathematics, OKC, OK – 1998
o    B.S., Biochemistry / Linguistics minor, Univ. of Oklahoma (magna cum laude), Norman, OK – 2002 
o    M.S., Microbiology & Immunology, Univ. of Oklahoma Health Sciences Center, OKC, OK – 2004 
o    Predoctoral Student (NIAID Trainee), Graduate Program in Biomedical Sciences – 2002-2003 
                                                         Department of Microbiology and Immunology – 2003-present 
              University of Oklahoma Health Sciences Center, OKC, OK – 2002-present 
             Arthritis & Immunology Program, Oklahoma Medical Research Foundation – 2003-present 
~ Doctoral Advisory Committee ~ 
PI and Major Advisor: Dr. Darise Farris
Members:
Dr. Rebecca Blackstock         Dr. Dan J.J. Carr 
Dr. Madeleine Cunningham
                                             Dr. Ann Louise Olson            Dr. Bill Rodgers
 
Research Experience / Training
o  1998 - OSSM Senior mentorship @ OUHSC with Dr. Thomas Seale
          Analysis of the Pharmacodynamics of Benzodiazepines
o  1998 - Totts Gap Medical Research Institute with Dr. Stewart Wolf, Jake Ebey, etc.
                  Summer focus: The Brain
o  2000-2002 - Honors Research and Thesis-OU Dept. of Chem. & Biochem. with Dr. Paul Cook
          Hydride Transfer Reaction Catalyzed by NAD-Malic Enzyme
o  2002-2003 - Graduate Program 1st Year Rotations
        1. OMRF with Dr. Carol Webb
          Analysis of the transcription factor Bright for topoisomerase activity
        2. OU College of Pharmacy with Dr. Rae Matsumoto
          Screening of six “YZ compound” analogs as potential sigma receptor antagonists for cocaine
        3. OMRF with Dr. Darise Farris
          Analysis of mechanisms of immune tolerance through SEB induced T cell anergy
o  2003-present – Doctoral Dissertation Research @ OMRF with Dr. Darise Farris 
          Analysis of T cell Tolerance Mechanisms in vivo Using Mouse Models:
                    Staph. Enterotoxin B-induced Anergy; Thymic Tolerance to human ribonucleoprotein La
o  September 2005 – PhosphoFlow 101 Training @ Stanford University, Dr. Garry Nolan
 
Honors and Awards
1998-1999 | Association for Women in Science Freshman Scholar – University of Oklahoma
1998-2002 | Robert C. Byrd Scholar
1998-2003 | Oklahoma Regents Scholar
1998-1999 | University of Oklahoma President’s Leadership Class
 1998        | American Academy of Achievement honoree - Jackson Hole, Wyoming
2001-2002 | Undergraduate Research Opportunities Program Grant Recipient
2001         | Univ. of Oklahoma Summer Undergraduate Research Fellowship, National Science Foundation
2002         | Who’s Who in American Colleges and Universities
2002         | 1 of 13 named to the University of Oklahoma Women’s Letzeiser Honor List
2002         | Phi Beta Kappa
2002-2003 | Alpha Gamma Delta Foundation Scholar
2003-2004 | Oklahoma Medical Research Foundation Predoctoral Fellowship
2004-pres. | OUHSC Immunology Trainee, National Institute of Allergy & Infectious Diseases 
2005         | OUHSC Graduate Student Association Award for Outstanding Academic Achievement
 
Memberships and Other Activities
o    University of Oklahoma Honors College – 1998-2002
o    Alpha Gamma Delta (VP Operations 1999, VP Scholarship 2000, Website Developer) – 1998-present
o    Alpha Epsilon Delta Medical Honors Fraternity – 1999-2002
o    Golden Key – 2001-present
o    Mortar Board – 2001-2002
o    Alpha Epsilon Lambda Graduate Student Honor Society – 2005-present
o    American Association of Immunologists – 2004-present
o    American Association for the Advancement of Science – 2005-present
~
o    Okla. School of Science and Math. Society Board of Trustees (Secretary 2003-2005) 
                                                                                         (President 2005-present) – 2001-present
o    University of Oklahoma Department of Chemistry and Biochemistry:
                        General Chemistry Teaching Assistant/Lab Instructor – Spring 2000
                        Organic Chemistry Lab Instructor – Summer 2000, 2002
o    Muscular Dystrophy Association Volunteer – 2002-present
o    American Heart Association Heart Walk 2005
 
Papers/Posters/Scientific Meetings
May 1998 ~ OSSM mentorship – Univ. of Oklahoma Health Sciences Center, OKC, OK 
                  (oral presentation; written report)
     “Of Mice and Men: Discovering Genes and the Pharmacodynamics of Benzodiazepines”


July 1998 ~ Summer Research Experience – Totts Gap Medical Research Institute, Bangor, PA 
                  (poster)
      “Can mental states be characterized by EEG analysis?”


July 2001 ~ Summer Undergraduate Research Fellowship – Univ. of Oklahoma, Norman, OK 
                  (poster; oral presentation)
October 2001 ~ 57th Annual Southwest Regional Meeting of the American Chemical Society – San Antonio, TX
                        (poster)
April 2002 ~ Undergraduate Research Day – Univ. of Oklahoma Honors College, Norman, OK 
                   (oral presentation)
May 2002 ~ Honors Undergraduate Research – Univ. of Oklahoma, Norman, OK 
                   (poster; Honors Thesis submitted)
      “Interaction of Residue Pair N478-N479 with the Nicotinamide Side Chain of NAD+ Is 
         Required for Proper Orientation in the Hydride Transfer Reaction Catalyzed by 
         NAD-Malic Enzyme”
       Jane C. Herron, Dali Liu, Paul F. Cook


June 2003 ~ Annual Meeting of the College on Problems of Drug Dependence – Bal Harbour, FL
                   (included in abstracts of two posters presented)
       “AC927, A Novel Ligand with Affinity for Dopamine Transporters and Sigma 
            Receptors, Attenuates Cocaine-Induced Behaviors in Mice,” 
          D.L. Gilmore, A. Coop, W.D. Bowen, B. Pouw, J.C. Yaciuk, R.R. Matsumoto

        “Six Novel Analogs of Bd1008 Attenuate Cocaine-Induced Convulsions in Mice: 
           Structure-Activity Relationships,”
         R.R. Matsumoto, J.C. Yaciuk, D.L. Gilmore, B. Pouw, W.D. Bowen, W. Williams, A. Coop



April 2004 ~ FASEB/American Association of Immunologists Annual Meeting – Washington D.C.
                   (included in abstract of poster presented)
       “Novel Gene Expression Changes in SEB-Anergized CD4+ Vb8+ T cells,”
         Sridevi Kurella, Jane C. Yaciuk, Igor Dozmorov, Michael Centola, A. Darise Farris


October 2004 ~ OUHSC/OMRF Immunology Retreat, Post Oak, Sand Springs, OK 
                        (oral presentation)
       “Are Defects in Lipid Raft Movement or Composition involved in T cell Anergy?”
        Jane C. Yaciuk, Sridevi Kurella, William A. Rodgers, and A. Darise Farris


March 2005 ~ OUHSC Graduate College GREAT Symposium, OKC, OK 
                     (oral presentation) 
  “Molecular Mechanisms of T cell Anergy: Role for LFA-1?”
   Jane C. Yaciuk, Sridevi Kurella, and A. Darise Farris


April 2005 ~ OCAST Grant Recipient Annual Poster Presentation, OKC, OK
“Molecular Basis of T cell Anergy"
 Sridevi Kurella,Ph.D., Jane C. Yaciuk, M.S., and A. Darise Farris, Ph.D.


July 21, 2005 ~ Genes and Immunity, aop 21 July 2005; doi: 10.1038/sj.gene.6364245
(Nature Publishing Group)
                    “Transcriptional modulation of TCR, Notch and Wnt Signaling Pathways
                      in SEB-Anergized CD4+ T cells"
                    S. Kurella,  J.C. Yaciuk, I Dozmorov, M.B. Frank, M Centola, and A.D. Farris


October 2005 ~ OUHSC/OMRF Immunology Retreat, Post Oak, Sand Springs, OK 
                        (oral presentation)
        “Characterization of T cell tolerance to the human ribonucleoprotein La using a 
            human La x TCR double transgenic mouse model” 
          Jane C. Yaciuk, Yujun Pan, Karen Davis, Jennifer Workman, Zijian Pan, and A. Darise Farris
 
Current Research Interests
 
          My graduate research focus is to analyze T cell tolerance mechanisms in vivo using mouse models.

          T cell anergy and suppression are likely responsible for tolerance to antigens that are the targets of many systemic autoimmune responses.  The molecular basis of T cell anergy maintenance and signaling involving lipid rafts and immune synapse formation are still largely unknown.  Analysis of lipid raft composition, movement, and synapse formation could shed light on the anergic T cell state. 

          Superantigens are known to initiate tolerance in some instances.  One experimental model of anergy induction in vivo utilizes Staphylococcal enterotoxin B (SEB.)  CD4+V?8+ T cells from SEB immunized mice become activated and experience one of two tolerogenic fates: apoptosis or survival in a non-functional state (anergy).  The SEB model has been well characterized in BALB/c mice, and, through its use as a somewhat physiologic example of tolerance, the long term goal is to identify possible surface molecule/cellular pathway differences between anergic and non-anergic T cells.

          I am also looking at mechanisms of tolerance to nuclear antigens; loss of tolerance to such autoantigens, about which little is known, is characteristic of systemic autoimmune disease.  Specifically, I am working on characterizing thymic tolerance in a mouse model developed in our lab.  This model is centered around the ribonucleoprotein La/SS-B, an autoimmune target in SLE (lupus) and Sjögren’s syndrome.  Mice transgenic for both human La (hLa) and an hLa specific T cell receptor are being analyzed to study central tolerance to human La.

          The goal of my studies is to contribute to an improved understanding of the molecular mechanisms of T cell tolerance and the loss thereof leading to autoimmunity. 


Click image to go back to Jane's Place main page.
This page last updated October 2005
Hosted by www.Geocities.ws

1